rs137854524
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PP3_ModeratePP5_Very_Strong
The NM_213599.3(ANO5):c.1295C>G(p.Ala432Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_213599.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- gnathodiaphyseal dysplasiaInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive limb-girdle muscular dystrophy type 2LInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- Miyoshi muscular dystrophy 3Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152026Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 250624 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461278Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 726964 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152026Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74222 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
- -
- -
- -
Autosomal recessive limb-girdle muscular dystrophy type 2L Pathogenic:1Other:1
- -
- -
Autosomal recessive limb-girdle muscular dystrophy Pathogenic:1
Variant summary: ANO5 c.1295C>G (p.Ala432Gly) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Four predict the variant creates cryptic 5' donor site. At least one publication reports experimental evidence that this variant affects mRNA splicing. Muscle cDNA from a homozygous patient confirmed aberrant splicing of exon 13 that resulted in the deletion of the last 38 nucleotides of this exon leading to a frameshift and a predicted premature truncation (p.Ala432GlyfsX49) (Bolduc_2010). The variant allele was found at a frequency of 2.8e-05 in 250624 control chromosomes (gnomAD). c.1295C>G has been reported in the literature in multiple individuals affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive (examples: Bolduc_2010, Levesque_2016, Silva_2019). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 20096397, 26809617, 31353849). Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
ANO5-related disorder Pathogenic:1
The ANO5 c.1295C>G variant is predicted to result in the amino acid substitution p.Ala432Gly. The c.1295C>G variant has been reported in the compound heterozygous state in several unrelated individuals to be causative for limb girdle muscular dystrophy 2L (Bolduc Véronique et al. 2010. PubMed ID: 20096397; Lévesque S. et al. 2016. PubMed ID: 26809617; http://www.LOVD.nl/ANO5). Functional studies found that this variant results in abnormal exon splicing (Bolduc Véronique et al. 2010. PubMed ID: 20096397). This variant is reported in 0.0062% of alleles in individuals of European (non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L;C2750076:Miyoshi muscular dystrophy 3 Pathogenic:1
- -
Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L Pathogenic:1
This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 432 of the ANO5 protein (p.Ala432Gly). RNA analysis indicates that this missense change induces altered splicing and may result in an absent or altered protein product. This variant is present in population databases (rs137854524, gnomAD 0.006%). This missense change has been observed in individuals with autosomal recessive limb-girdle muscular dystrophy (PMID: 20096397, 26809617, 31353849). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2163). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ANO5 protein function. Studies have shown that this missense change results in activation of a cryptic splice site, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 20096397). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at